Mersana Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Mersana Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Mersana Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.43M, a 33.4% decline year-over-year.
  • Mersana Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $17.2M, a 27.7% decline year-over-year.
  • Mersana Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $21.1M, a 1.79% decline from 2022.
  • Mersana Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $21.5M, a 16.9% increase from 2021.
  • Mersana Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.4M, a 157% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21.1M -$386K -1.79% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $21.5M +$3.11M +16.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $18.4M +$11.2M +157% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $7.17M +$2.3M +47.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $4.87M +$988K +25.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $3.88M +$2.46M +173% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $1.42M +$758K +114% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $664K +$315K +90.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 $349K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.